Subscribe to Technical Bulltin
Tips
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion c
1
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion c
2

Protocal

  • [Literature Review] CRISPR/Cas9 Cellular Reporter System to Evaluate Fetal Hemoglobin Induction and Therapeutic Screening

    LATEST DISCOVERY

    [Literature Review] CRISPR/Cas9 Cellular Reporter System to Evaluate Fetal Hemoglobin Induction and Therapeutic Screening

  • [Literature Review] CRISPR screening reveals that removal of TREX1 enhances CRISPR-Cas9-mediated homology-directed repair

    LATEST DISCOVERY

    [Literature Review] CRISPR screening reveals that removal of TREX1 enhances CRISPR-Cas9-mediated homology-directed repair

  • [Literature Review] Deadly RNA: CRISPR Screening Reveals RP11-350G8.5 as a Key Target for Multiple Myeloma Treatment

    LATEST DISCOVERY

    [Literature Review] Deadly RNA: CRISPR Screening Reveals RP11-350G8.5 as a Key Target for Multiple Myeloma Treatment

  • [Literature Review] CRISPR Knockout: A Breakthrough in Nrf2 Activation for Kidney Disease Treatment

    LATEST DISCOVERY

    [Literature Review] CRISPR Knockout: A Breakthrough in Nrf2 Activation for Kidney Disease Treatment

  • [Literature Review] CRISPR Sparks Innovation: CreDiT Assay Redefines Diagnostics for Underserved Areas

    LATEST DISCOVERY

    [Literature Review] CRISPR Sparks Innovation: CreDiT Assay Redefines Diagnostics for Underserved Areas

  • [Literature Review] CRISPR Knockout Provides Novel Insight into CENP-E-mediated Cell Division

    LATEST DISCOVERY

    [Literature Review] CRISPR Knockout Provides Novel Insight into CENP-E-mediated Cell Division

  • [Literature Review] CRISPR Screening Innovation: A Novel Tool for Higher-Order Genetic Perturbations

    LATEST DISCOVERY

    [Literature Review] CRISPR Screening Innovation: A Novel Tool for Higher-Order Genetic Perturbations

EDGENE

Contact US

web logo
Kathy
Tel: info@editxor.com
Tel: 833-2263234
(USA Toll-free)
Tel: +1-224-345-1927
(USA)
Tel: +86-19120353110
(Intl)
在线客服